Table 2.
Baseline characteristics of participants in training and control group within two insomnia phenotypes
| ISSD | p | INSD | p | |||
|---|---|---|---|---|---|---|
| Training (N = 21) | Control (N = 19) | Training (N = 19) | Control (N = 20) | |||
| Male, no. (%) | 5(23.8%) | 4(21.1%) | 0.855a | 3(15.8%) | 4(20.0%) | 0.732a |
| Age, years | 20.57(1.54) | 20.32(1.89) | 0.491b | 20.42(1.50) | 21.05(2.09) | 0.677b |
| NoGo-ACC | 0.88(0.07) | 0.86(0.07) | 0.476b | 0.92(0.07) | 0.90(0.06) | 0.338b |
| PSQI | 10.33(2.18) | 10.32(1.77) | 0.848b | 9.95(1.96) | 9.90(2.83) | 0.541b |
| PSQI-TST, min | 384.29(64.08) | 397.89(58.17) | 0.488c | 394.75(58.53) | 399.00(63.15) | 0.729b |
| ISI | 14.14(3.35) | 15.00(2.62) | 0.137b | 15.47(2.67) | 15.45(4.43) | 0.552b |
| PSAS | 45.86(10.22) | 49.26(10.83) | 0.162b | 45.32(9.83) | 49.70(10.53) | 0.188c |
| PSAS-SA | 19.38(5.30) | 20.74(6.12) | 0.457c | 16.89(6.57) | 20.45(5.69) | 0.079c |
| PSAS-CA | 26.48(6.27) | 28.53(6.42) | 0.232b | 28.42(5.17) | 29.25(6.05) | 0.649c |
| TST, min | 371.55(43.98) | 345.79(58.44) | 0.083b | 508.03(60.56) | 513.70(94.43) | 0.833b |
| SL, min | 68.02(56.30) | 45.82(42.77) | 0.180b | 47.42(38.2) | 50.05(54.16) | 0.933b |
| WT, min | 49.07(45.75) | 42.05(49.47) | 0.542b | 89.5(68.79) | 103.73(99.12) | 0.922b |
| LST, min | 210.40(45.84) | 200.34(65.08) | 0.572c | 273.53(49.03) | 239.38(87.69) | 0.060b |
| DST, min | 52.86(33.76) | 53.32(23.8) | 0.961c | 58.45(30.12) | 70.93(33.87) | 0.233c |
| PSQISQ | 1.95(0.38) | 1.95(0.4) | 0.965b | 2.00(0.47) | 2.10(0.55) | 0.532b |
| PSQILATEN | 2.19(0.75) | 2.47(0.61) | 0.229b | 2.26(0.65) | 2.15(0.88) | 0.774b |
| PSQIDURAT | 1.05(1.02) | 0.63(0.68) | 0.219b | 0.63(0.76) | 0.55(1.00) | 0.409b |
| PSQISE | 0.95(1.02) | 0.63(0.9) | 0.258b | 0.95(0.78) | 0.70(0.98) | 0.205b |
| PSQIDISTB | 1.33(0.48) | 1.79(0.71) | 0.057b | 1.63(0.68) | 1.75(0.72) | 0.601b |
| PSQIUOSN | 0.24(0.77) | 0.05(0.23) | 0.573b | 0(0) | 0.05(0.22) | 0.330b |
| PSQIDF | 2.62(0.5) | 2.79(0.42) | 0.361b | 2.47(0.77) | 2.60(0.60) | 0.728b |
ISSD Insomnia with objective short sleep duration, INSD Insomnia with objective normal sleep duration, NoGo-ACC accuracy of correct NoGo trials in the Go/NoGo task, PSQSI Pittsburg Sleep Quality Index, PSQI-TST Subjective Total Sleep Duration reported by PSQI’s item 4, ISI Insomnia Severity Index, PSAS Pre-sleep arousal scale, SA Somatic arousal, CA Cognitive arousal, TST Total Sleep Time, SL Sleep Latency, WT Wakefulness Time, LST Light Sleep Time, DST Deep Sleep Time, PSQISQ PSQI Sleep Quality, PSQILATEN PSQI Sleep Latency, PSQIDURAT PSQI Sleep Duration, PSQISE PSQI Sleep Efficiency, PSQIDISTB PSQI Sleep Disturbance, PSQIUOSM PSQI Use of Sleep Medicines, PSQIDF PSQI Daytime Functioning
athe p-value of χ2 t-test
bthe p-value of Mann–Whitney U test
cthe p-value of two sample t test